Skip to main content
. Author manuscript; available in PMC: 2011 Jan 21.
Published in final edited form as: Adv Inorg Chem. 2009 Jul 7;61:1–62. doi: 10.1016/S0898-8838(09)00201-3

Figure 23.

Figure 23

a) The [Ru(η6-arene)(azpy)I]+ complex (17a) is a catalytically active ruthenium-arene anticancer agent; (b) remarkable influence of the leaving group on cytotoxic activity; c) [Ru(η6-arene)(azpy)I]+ complexes can act as catalysts for the oxidation of the major intracellular reducing agent glutathione to glutathione disulfide with concomitant production of reactive oxygen species. Data from ref 77.